Trieu Vuong - Jan 29, 2025 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role: CHAIRMAN AND CEO, Director, 10%+ Owner
Signature: /s/ Trieu, Vuong
Stock symbol: OTLC
Transactions as of: Jan 29, 2025
Transactions value $: $9,712
Form type: 4
Date filed: 1/31/2025, 05:08 PM
Previous filing: Nov 26, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership
transaction	OTLC	Common Stock	Purchase	$5.13K	+183K	+0.2%	$0.03	93M	Jan 29, 2025	Direct
transaction	OTLC	Common Stock	Purchase	$2.8K	+100K	+0.11%	$0.03	93.1M	Jan 30, 2025	Direct
transaction	OTLC	Common Stock	Purchase	$1.79K	+63.8K	+0.07%	$0.03	93.2M	Jan 31, 2025	Direct
holding	OTLC	Common Stock						16.8M	Jan 29, 2025	By Autotelic, Inc.
holding	OTLC	Common Stock						6.87M	Jan 29, 2025	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Between January 29, 2025 and January 31, 2025, Dr. Trieu purchased 346,844 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.028.